Literature DB >> 4488339

Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activity.

M I Marks, M Rabinovitch, R MacKenzie, M Brazeau.   

Abstract

One hundred and forty isolates of beta-hemolytic streptococcus cultured from patients with clinical pharyngitis were studied by disc diffusion for antibiotic sensitivity to lincomycin, erythromycin, cephalexin and penicillin and by agar dilution to cephalexin and penicillin. All isolates were sensitive to </= 0.1 mug./ml. penicillin and </= 1.56 mug./ml. cephalexin. The disc-diffusion test was reliable in predicting the sensitivities in vitro. One strain of group A betahemolytic streptococcus was resistant to erythromycin by disc diffusion. When compared to Lancefield grouping 18% of strains were incorrectly identified as group A by the bacitracin-disc test. Cephalexin was uniformly effective in vitro in inhibiting beta-hemolytic streptococci and the 30 mug. cephalexin disc was reliable in predicting these sensitivities.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4488339      PMCID: PMC1941413     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Streptococcal tonsillitis in general practice. A comparison of cephalexin and penicillin therapy.

Authors:  D W Gau; R F Horn; R M Solomon; P Johnson; D A Leigh
Journal:  Practitioner       Date:  1972-02

2.  Treatment of group A streptococcal pharyngitis in children. Comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly.

Authors:  V M Howie; J H Ploussard
Journal:  Am J Dis Child       Date:  1971-06

3.  Rapid fluorescent-antibody stain technique with group A streptococci.

Authors:  P W Freeburg
Journal:  Appl Microbiol       Date:  1970-06

4.  Comparison of cephalothin, cephaloridine, cephalexin and cephaloglycin in streptococcal infections in monkeys.

Authors:  S Saslaw; H N Carlisle
Journal:  Am J Med Sci       Date:  1969-06       Impact factor: 2.378

5.  Streptococcal pharyngitis. Evaluation of erythromycin, erythromycin-sulfas, and sulfamethoxazole (possible antagonism between erythromycin and sulfas).

Authors:  W T Hughes; R N Collier
Journal:  Am J Dis Child       Date:  1969-11

6.  Cephalexin: in vitro bacterial susceptibility, absorption in volunteers, and antibacterial activity of sera and urine.

Authors:  R L Perkins; H N Carlisle; S Saslaw
Journal:  Am J Med Sci       Date:  1968-08       Impact factor: 2.378

7.  Cephalexin--a new oral cephalosporin: clinical evaluation in sixty-three patients.

Authors:  R J Fass; R L Perkins; S Saslaw
Journal:  Am J Med Sci       Date:  1970-03       Impact factor: 2.378

8.  Rapid extraction method with pronase B for grouping beta-hemolytic streptococci.

Authors:  G M Ederer; M M Herrmann; R Bruce; J M Matsen; S S Chapman
Journal:  Appl Microbiol       Date:  1972-02

9.  Streptococcal pharyngitis therapy: comparison of cyclacillin, cephalexin, and potassium penicillin V.

Authors:  M Stillerman; H D Isenberg
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

10.  Cephalexin, a new orally absorbed cephalosporin antibiotic.

Authors:  W E Wick
Journal:  Appl Microbiol       Date:  1967-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.